Abbott Opens New Preclinical Lab In Singapore - Its First Pharma R&D Outpost In Southeast Asia
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Abbott opened a new preclinical laboratory in Singapore's Biopolis research park Jan. 20., which marked the company's first pharma R&D site in Southeast Asia. The new facility will conduct stability studies, including studies on active pharmaceutical ingredients and novel formulations to support global regulatory filings
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)